3.54 USD
↘ 0.20 (5.35%)AT CLOSE (11:59 AM EDT)
Alvotech Ordinary Shares
ALVONASDAQ • USD
3.33
↘ 0.21 (5.93%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
3.33
↘ 0.21 (5.93%)
Market: CLOSED
Open?$3.69
High?$3.73
Low?$3.48
Prev. Close?$3.74
Volume?694.1K
Avg. Volume?N/A
VWAP?$3.59
Bid / Ask
Bid?$2.95 × 1.8K
Ask?$3.71 × 300
Spread?$0.76
Midpoint?$3.33
Valuation & Ratios
Market Cap?1.1B
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Alvotech Ordinary Shares (ALVO) is currently trading at $3.54. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?55
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.44Distress
Confidence?37%Very Low
Short InterestHigh
Short Interest?2.5M
Days to Cover?6.0
Avg Daily Volume424.7K
Settlement Date2026-05-15